These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23484886)

  • 1. Anaphylaxis in the allergist's office: preparing your office and staff for medical emergencies.
    Wallace DV
    Allergy Asthma Proc; 2013; 34(2):120-31. PubMed ID: 23484886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing anaphylaxis in the office setting.
    Cingi C; Wallace D; Bayar Muluk N; Ebisawa M; Castells M; Şahin E; Altıntoprak N
    Am J Rhinol Allergy; 2016 Jul; 30(4):118-23. PubMed ID: 27456586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.
    Epstein TG; Liss GM; Berendts KM; Bernstein DI
    J Allergy Clin Immunol Pract; 2019; 7(6):1996-2003.e1. PubMed ID: 30776526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergists' self-reported adherence to anaphylaxis practice parameters and perceived barriers to care: an American College of Allergy, Asthma, and Immunology member survey.
    Fineman S; Dowling P; O'Rourke D
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):529-36. PubMed ID: 24267364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of subcutaneous allergen immunotherapy.
    Bernstein DI; Epstein TG
    Allergy Asthma Proc; 2022 Jul; 43(4):267-271. PubMed ID: 35818150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?
    Fitzhugh DJ; Bernstein DI
    J Allergy Clin Immunol Pract; 2016; 4(5):862-7. PubMed ID: 27209596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Normative documents of the Spanish Society for Pediatric Clinical Immunology and Allergology. Minimum requirements for practicing the specialty of pediatric allergy and immunology in a hospital setting].
    SEICAP
    Allergol Immunopathol (Madr); 2003; 31(3):192-7. PubMed ID: 12809131
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):426-431.e1. PubMed ID: 22018614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.
    Phillips JF; Lockey RF; Fox RW; Ledford DK; Glaum MC
    Allergy Asthma Proc; 2011; 32(4):288-94. PubMed ID: 21781404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists].
    Larenas Linnemann D; Rodríguez Pérez N; Becerril M
    Rev Alerg Mex; 2008; 55(2):62-70. PubMed ID: 19058483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylaxis in the allergy practice.
    Leatherman BD
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S60-5. PubMed ID: 25182358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic emergencies in the physician's office.
    Greenberger PA
    Clin Rev Allergy Immunol; 1999; 17(4):401-12. PubMed ID: 10829810
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergy immunotherapy safety: location matters!
    Cox L; Aaronson D; Casale TB; Honsinger R; Weber R
    J Allergy Clin Immunol Pract; 2013; 1(5):455-7. PubMed ID: 24565616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis: still a ghost behind allergen immunotherapy.
    Makatsori M; Calderon MA
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):316-22. PubMed ID: 24873937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to otolaryngic allergy emergencies.
    Hunsaker DH
    Otolaryngol Clin North Am; 1998 Feb; 31(1):207-19. PubMed ID: 9530687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):274-8, 278.e1. PubMed ID: 23535092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.